Trudel, S., Beksac, M., Pour, L., Delimpasi, S., Quach, H., Vorobyev, V. I., Cavo, M., Suzuki, K., Robak, P., Morris, K., Lin, C. P., Garrobo-Calleja, I., Fulci, G., Manasanch, E., Kremer, B., Mateos, M., Dimopoulos, M. A. (2025). DREAMM-8 study of belantamab mafodotin plus pomalidomide and dexamethasone (BPd) vs pomalidomide plus bortezomib and dexamethasone (PVd) in relapsed/refractory multiple myeloma (RRMM): A subgroup analysis in patients with high-risk cytogenetic features.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7533